PhD, Adjunct Professor in Cancer Biology Kaisa Huhtinen - UTU Research Portal

Kaisa Huhtinen
PhD, Adjunct Professor in Cancer Biology

- Docent,
Faculty of Medicine (University of Turku)

kaisa.huhtinen@utu.fi

+358 29 450 2645

+358 50 572 6733

Kiinamyllynkatu 10

Turku

: D5038

: https://orcid.org/0000-0001-9685-5246

ResearchGate_Kaisa_Huhtinen

Ovarian cancer; personalized medicine; early diagnostics; prediction; prognosis; biomarker; genomics; drug target; interdicipline research;

4 of 8

Analysis of single-cell RNA-seq data from ovarian cancer samples before and after chemotherapy links stress-related transcriptional profile with chemotherapy resistance (2020)
- bioRxiv
Zhang K, Erkan EP, Dai J, Andersson N, Kaipio K, Lamminen T, Mansuri N, Huhtinen K, Carpen O, Hynninen J, others
A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions (2020)
- Scientific Data
Gabriel M, Fey V, Heinosalo T, Adhikari P, Rytkönen K, Komulainen T, Huhtinen K, Laajala TD, Siitari H, Virkki A, Suvitie P, Kujari H, Aittokallio T, Perheentupa A, Poutanen M
Exploratory Analysis of CA125-MGL and –STn Glycoforms in the Differential Diagnostics of Pelvic Masses (2020)
- The Journal of Applied Laboratory Medicine
Liina Salminen, Nimrah Nadeem, Anne Lone Rolfsen, Anne Dørum, Teemu D Laajala, Seija Grènman, Sakari Hietanen, Taija Heinosalo, Antti Perheentupa, Matti Poutanen, Nils Bolstad, Olli Carpén, Urpo Lamminmäki, Kim Pettersson, Kamlesh Gidwani, Johanna Hynninen, Kaisa Huhtinen
Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125 (2020)
- Communications Biology
Sherif Bayoumy, Heidi Hyytiä, Janne Leivo, Sheikh M. Talha, Kaisa Huhtinen, Matti Poutanen, Johanna Hynninen, Antti Perheentupa, Urpo Lamminmäki, Kamlesh Gidwani & Kim Pettersson
HE4 in the evaluation of tumor load and prognostic stratification of high grade serous ovarian carcinoma (2020)
- Acta Oncologica
Liina Salminen, Kamlesh Gidwani, Seija Grènman, Olli Carpén, Sakari Hietanen, Kim Pettersson, Kaisa Huhtinen, Johanna Hynninen
RNA-seq analysis of high-grade serous ovarian cancer patients before and after chemotherapy reveals chemoresistance-associated genes and pathways (2020)
- Clinical Cancer Research
Jamalzadeh S, Zhang KY, Hakkinen A, Huhtinen K, Hynninen J, Andersson N, Mansuri N, Carpen O, Erdogan E, Dai J, Vaharautio A, Hietanen S, Oikkonen J, Lehtonen R, Hautaniemi S
Singling out tumor heterogeneity and chemoresistance in high-grade serous ovarian cancer (2020)
- Clinical Cancer Research
Erkan EP, Dai J, Zhang KY, Kaipio K, Lamminen T, Mansuri N, Suominen L, Alkodsi A, Huhtinen K, Hietanen S, Hynninen J, Grenman S, Carpen O, Hautaniemi S, Vaharautio A
CtDNA profiling to predict prognosis and optimize treatment in high-grade serous ovarian cancer (2019)
- Clinical Cancer Research
Oikkonen J, Zhang KY, Salminen L, Huhtinen K, Schulman I, Andersson N, Carpen O, Hietanen S, Grenman S, Lehtonen R, Hynninen J, Farkkila A, Hautaniemi S
Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources (2019)
- The Journal of Applied Laboratory Medicine
Gidwani K, Nadeem N, Huhtinen K, Kekki H, Heinosalo T, Hynninen J, Perheentupa A, Poutanen M, Carpen O, Pettersson K, Lamminmäki U
Prospective Longitudinal ctDNA Workflow Reveals Clinically Actionable Alterations in Ovarian Cancer (2019)
- JCO Precision Oncology
Oikkonen J, Zhang KY, Salminen L, Schulman I, Lavikka K, Andersson N, Ojanperä E, Hietanen S, Grenman S, Lehtonen R, Huhtinen K, Carpen O, Hynninen J, Färkkilä A, Hautaniemi S